All sponsors

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS14
PHASE 3 / 2-37
RECRUITING9
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO17%

Delay Index: of 6 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
SSGJ-707
NCT06493760
P2RecruitingMetastatic Colorectal Cancer1302025-06
608
NCT06222671
P2RecruitingAxial Spondyloarthritis1802025-09-22
611
NCT06639295
P3Active, not recruitingSinusitis; Nasal Polyps2432025-12
611
NCT07042126
P3RecruitingDermatitis, Atopic1802026-06-30
608 dose
NCT07261644
P3RecruitingAnkylosing Spondylitis5002027-01-14
610
NCT06680947
P2Active, not recruitingAsthma2252027-02 (+5 mo)
610
NCT06323213
P3RecruitingAsthma4802027-02 (+8 mo)
SSGJ-613 100 mg Q12W
NCT07708181
P2Not yet recruitingGout Arthritis2002027-08-11
611
NCT07767253
P3RecruitingDermatitis, Atopic2462027-09
608
NCT07349329
P3Not yet recruitingAxial Spondyloarthritis, Non-Radiographic3802028-04-19
626
NCT07185269
P1/2RecruitingSystemic Lupus Erythematosus (SLE)1982028-08-12
611
NCT07039669
P3RecruitingPulmonary Disease, Chronic Obstructive (COPD)5942028-09
NCT07900867
NCT07900867
P2Not yet recruitingCutaneous Lupus Erythematosus (CLE)1402028-12
627
NCT07507513
P2RecruitingUlcerative Colitis (UC)2882029-02-28